Global Market Access Archives - Page 2 of 2

04/02/2021

15

4 roadblocks facing orphan medicines seeking to achieve market access in Europe - Part 2 Clinical evidence development. From Mtech Access

Challenges for orphan medicines entering the European market – Part 2: Clinical evidence development

By Mtech Team | Evidence, Global Market Access, Pharma | 2 Comments

In this four-part series, we explore the various challenges facing orphan medicines entering the European market and suggest solutions that can help improve patient access. In Part 2 of the...

26/01/2021

2

4 roadblocks facing orphan medicines seeking to achieve market access in Europe: Part 1 of 4: Disease Knowledge and Awareness

Challenges for orphan medicines entering the European market – Part 1: Disease knowledge and awareness

By Mtech Team | Global Market Access, Pharma | 3 Comments

In this four-part series, we explore the various challenges facing orphan medicines entering the European market and suggest solutions that can help improve patient access. In Part 1, we explore...

02/12/2020

23

Changing spending priorities in pharmaceutical market access: pressures facing AIFA and other European agencies in a post-COVID era

By Global Faculty | Global Market Access | No Comments

Guest author Professor Fabrizio Gianfrate shares his thoughts on how spending priorities have shifted in the pandemic, how they may further evolve in a post-COVID era, and how European agencies...

02/10/2020

24

Three themes from the World Pharma Pricing Market Access & Evidence Congress

By Mtech Team | Evidence, Global Market Access, Events & Conferences, Medical Writing, Pharma, HTA | No Comments

Mtech Access attended the virtual World Pharma Pricing Market Access & Evidence Congress on 23–25th September 2020, where our team were inspired by the range of seminars, round tables and...

22/06/2020

17

Mtech Access is now a corporate member of BHBIA

By Lily Sanders | News, Evidence, Global Market Access | No Comments

We are delighted to announce that Mtech Access has been accepted as a corporate member of the British Healthcare Business Intelligence Association (BHBIA). At Mtech Access, we support our pharma...

11/02/2020

3

celebrating international day of women and girls in science

Celebrating International Day of Women & Girls in Science

By Lily Sanders | News, Careers, Global Market Access, NHS Insights | No Comments

Each year, on 11th February, the United Nations and the global scientific community celebrate the International Day of Women and Girls in Science. Women are underrepresented in science and are...

12/07/2019

0

Explore the opportunities with our Global Market Access team

By Lily Sanders | News, Global Market Access

We understand that the path to successful global market access and uptake is complex and multi-faceted. Defining robust pricing and market access strategies, and developing meaningful value strategies, are essential...

Monday	09:00 – 18:00
Tuesday	09:00 – 18:00
Wednesday	09:00 – 18:00
Thursday	09:00 – 18:00
Friday	09:00 – 18:00
Saturday	Closed
Sunday	Closed

Global Market Access

Challenges for orphan medicines entering the European market – Part 2: Clinical evidence development

Challenges for orphan medicines entering the European market – Part 1: Disease knowledge and awareness

Changing spending priorities in pharmaceutical market access: pressures facing AIFA and other European agencies in a post-COVID era

Three themes from the World Pharma Pricing Market Access & Evidence Congress

Mtech Access is now a corporate member of BHBIA

Celebrating International Day of Women & Girls in Science

Explore the opportunities with our Global Market Access team

Insights Newsletter

Recent Posts

Archives

Categories

Company Information

Registed Address

Cookie Consent Settings

Contact Information

Office Hours (GMT)

Mtech Demo Portal